Cargando…
Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
Chronic cough, defined as a cough lasting > 8 weeks, is a common medical condition that exerts a substantial physical, mental, and social burden on patients. A subset of patients with chronic cough are troubled with a cough that persists despite optimal treatment of presumed associated common and...
Autores principales: | Mazzone, Stuart B., McGarvey, Lorcan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983941/ https://www.ncbi.nlm.nih.gov/pubmed/32748976 http://dx.doi.org/10.1002/cpt.2003 |
Ejemplares similares
-
Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
por: Muccino, David R., et al.
Publicado: (2020) -
Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks
por: Birring, Surinder S., et al.
Publicado: (2023) -
Recent progress in the management of chronic cough
por: Song, Woo-Jung, et al.
Publicado: (2020) -
From bench to bedside: The role of cough hypersensitivity in chronic cough
por: Drake, Matthew G., et al.
Publicado: (2023) -
Cough hypersensitivity and chronic cough
por: Chung, Kian Fan, et al.
Publicado: (2022)